Blood-brain barrier
More than 100 years ago it was discovered that if blue dye was injected into the bloodstream of an animal, that tissues of the whole body except the brain and spinal cord would turn blue. To explain this, scientists thought that a "Blood-Brain-Barrier" (BBB) which prevents materials from the blood from entering the brain existed. The BBB is semi-permeable; that is, it allows some materials to cross, but prevents others from crossing. In most parts of the body, the smallest blood vessels, called capillaries, are lined with endothelial cells. Endothelial tissue has small spaces between each individual cell so substances can move readily between the inside and the outside of the vessel. However, in the brain, the endothelial cells fit tightly together and substances cannot pass out of the bloodstream.
- Neuromyelitis Optica
- Cell based therapies
- Immunomodulation
- Brain-immune loop conjunction
- Ion channel disorder
- Disease confined to Blood Brain Barrier
- Vascular Neurology
Related Conference of Blood-brain barrier
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
2nd International Conference on Brain disorder and therapeutics
2nd International Conference on Neurological Disorder and Stroke
2nd International Conference on Parasitology
Global Neuroscience conference
5th Neurology Congress
5th Alzheimer s disease and Dementia Conference
2nd Brain Disorders Conference
2nd Neurological Disorders and Stroke Conference
4th Vascular Dementia Conference
4th International Conference on Vascular Dementia
Barriers of the CNS Gordon Research Conference
Blood Brain Barrier BBB Meeting
Blood Brain Barrier congress
2nd International Conference on Innate Immunity
International Conference on Hepatitis Vaccines
BioMed Conference Blood Brain Barrier
Canadian society of allergy and clinical immunology annual meeting 2015
Spanish society of allergy and clinical immunology 31st annual congress 2015
2nd international primary immunodeficiencies congress 2015
American college of allergy asthma and immunology annual meeting 2015
14th Transplantation science symposium 2015
Japanese society for immunology 44th annual meeting 2015
Australian society for immunology 45th annual meeting 2015
Turkish national allergy and clinical immunology association 22nd annual meeting 2015
Austrian society of allergology and immunology annual symposium 2015
8th I mmunotherapeutics Immunomonitoring conference 2016
keystone symposia cell biology and immunology of persistent infection 2016
Blood-brain barrier Conference Speakers
Recommended Sessions
- Antibody-mediated disorders
- Applied Neurobiology
- Autoimmune neuropathies
- Blood-brain barrier
- Brain-Computer Interface
- Clinical Neuroimmunology
- Fundamental immunology
- Neuro-immune interaction
- Neurodegenerative diseases
- Neuroimmunological infectious diseases
- Neuroimmunology
- Neuroinflammation
- Neurology
- Neuropharmacology
- Neurovirology
- Psychoneuroimmunology
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (Italy)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (Italy)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Epidemiology - European Immunology 2025 (Italy)
- Immune System - European Immunology 2025 (Italy)
- Immunodeficiency - European Immunology 2025 (Italy)
- Immunogenetics - European Immunology 2025 (Italy)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (Italy)
- Immunological Techniques - European Immunology 2025 (Italy)
- Immunology - European Immunology 2025 (Italy)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunotherapy - European Immunology 2025 (Italy)
- Immunotoxicology - European Immunology 2025 (Italy)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Neuroimmunology - European Immunology 2025 (Italy)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Parasite Immunology - European Immunology 2025 (Italy)
- Pediatrics Immunology - European Immunology 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Reproductive Immunology - European Immunology 2025 (Italy)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Transplantation Immunology - European Immunology 2025 (Italy)
- Viral Immunology - European Immunology 2025 (Italy)